Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Complementary and Integrative Medicine

Editor-in-Chief: Lui, Edmund

Ed. by Ko, Robert / Leung, Kelvin Sze-Yin / Saunders, Paul / Suntres, PH. D., Zacharias

CiteScore 2017: 1.41

SCImago Journal Rank (SJR) 2017: 0.472
Source Normalized Impact per Paper (SNIP) 2017: 0.564

See all formats and pricing
More options …

A randomized comparative study of herbal decoction of Cassia fistula Linn pod's pericarp and Myristica fragrans Houtt arils vs. mefenamic acid in spasmodic dysmenorrhoea

Amera Anjum / Arshiya Sultana
  • Corresponding author
  • Dept of Ilmul Qabalat wa Amraze Niswan (OBG), National Institute of Unani Medicine, Bengaluru, India
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2018-10-12 | DOI: https://doi.org/10.1515/jcim-2018-0105



To compare the efficacy and safety of herbal decoction (pods of Cassia fistula Linn. and Arils of Myristica fragrans Houtt) with mefenamic acid in spasmodic dysmenorrhoea.


In this single-blind, prospective, parallel, standard controlled study, dysmenorrheic patients (n=64) were randomly allocated to receive herbal decoction (n=31) or mefenamic acid (n=33) for two consecutive menstrual cycles. Treatment group received 180 mL herbal decoction of post amaltas (Cassia fistula L pod’s pericarp) (21 g), bisbasah (Myristica fragrans Houtt arils) (3 g) and qand siyah (jaggery) (30 g) which were orally administered at morning for 3 days before the expected start of menstruation. The control group received mefenamic acid 500 mg orally twice daily between day 1 and day 3 of menstruation. The primary outcomes were visual analog scale (VAS) for pain intensity, pain relief scale and the safety assessment by clinical examination and biochemical parameters. The secondary outcomes included health-related quality of life (HRQoL) determined by SF-12 health survey questionnaire, duration of pain and pictorial blood assessment chart score for menstrual blood loss. The data were statistically interpreted with 5% level of significance.


At the baseline, on day 1, pain severity for VAS score between the groups [7.09 ± 1.07 vs. 6.75 ± 1.09] had no significant difference (p>0.05). However, during the second menstrual cycle, a significant reduction [0.03 + 0.17 vs. 0.42 + 1.44] in pain severity on day 1 was noted in both groups (p<0.001). During the second menstrual cycle, improvement in HRQoL health survey [SF-12 total score: 85.88 ± 5.99 vs 74.83 ± 15.9] and reduction in pain duration were significantly higher in the treatment group compared to the control group. No side effects were reported.


Herbal decoction was effective to relieve pain and to improve HRQoL in spasmodic dysmenorrhoea.

Keywords: bisbasah (arils of Myristica fragrans Houtt); dysmenorrhea; post amaltas (pod's pericarp of Cassia fistula); SF-12 health survey questionnaire; VAS score for pain intensity


  • [1]

    Hong JU, Jones M, Mishra G. The prevalence and risk factors of dysmenorrhoea. Epidemiol Rev. 2014;36:104–13.PubMedCrossrefGoogle Scholar

  • [2]

    Sina I. Al Qanoon Fit Tib. (Urdu Trans: kantoori G H). New Delhi: IdaraeKitabus Shifa, 2010:1094–1095, 1096, 1118.Google Scholar

  • [3]

    Habibi N, Huang MS, Gan WY, Zulida R, Safavi SM. Prevalence of primary dysmenorrhoea and factors associated with its intensity among under graduate students: A cross sectional study. Pain Manag Nurs. 2015;16:855–61.CrossrefGoogle Scholar

  • [4]

    Kural MR, Noor NN, Pandit D, Joshi T, Patil A. Menstrual characteristics and prevalence of dysmenorrhoea in college going girls. J Family Med Prim Care. 2015;4:426–31.CrossrefPubMedGoogle Scholar

  • [5]

    Chen CX, Barrett B. Kwekkeboom KL efficacy of oral ginger (Zingiber officinale) for dysmenorrhoea: a systemic review and meta-analysis. Evid Based Compl Alt Med 2016. 2016;6295737. DOI: .CrossrefGoogle Scholar

  • [6]

    Khorshidi N, Ostad SN, Mosaddegh M, Soodi M. Clinical effects of fennel essential oil on primary dysmenorrhoea. Iran J Pharm Res. 2003;2:89–9315.Google Scholar

  • [7]

    Ortiz MI, Rangel-Flores E, Carrillo-Alarcon LC, Veras-Godoy HA. Prevalence and impact of primary dysmenorrhea among Mexican high school students. Int J Gynaecol Obstet. 2009;107:240–43.CrossrefPubMedGoogle Scholar

  • [8]

    Khare D, Jain P. Effect of different exercise techniques on primary dysmenorrhoea among higher secondary school girls. Int J Sci Res. 2016;5:e1–e4.Google Scholar

  • [9]

    Awed H, EL-Saidy T, Amro T. The use of fresh ginger herbs as a home remedy to relieve primary dysmenorrhoea. J Res Nurs Midwifery. 2013;2:104–13.Google Scholar

  • [10]

    Ghani N. Khazainul Advia. New Delhi: Idarae Kitabus Shifa;YNM, 2001;264–7, 572–3.Google Scholar

  • [11]

    Khan A. Al Akseer. Vol II (Urdu Trans: kabeeruddin M). New Delhi: IdaraeKitabus Shifa, 2003:780–81.Google Scholar

  • [12]

    Mirabi P, Alamolhoda SH, Esmaelizadeh S, Mojab F. Effects of medicinal herbs on primary dysmenorrhoea-A systemic review. Iran J Pharm Res. 2014;13:757–67. PMCID: PMC4177637.Google Scholar

  • [13]

    Rigi SN, Kermansaravi F, Navidian A, Safabakhsh L, Safarzadeh A, Khazaian S, et al. Comparing the analgesic effect of heat patch containing iron chip and ibuprofen for primary dysmenorrhea: a randomized controlled trial. BMC Women's Health. 2012;12:25 .PubMedCrossrefGoogle Scholar

  • [14]

    Ozaki Y, Soedidgo S, Wattimena YR, Suganda AG. Anti-inflammatory effect of mace, aril of Myristica fragrans Houtt., and its active principles. Jpn J Pharmacol. 1989;49:155–63.CrossrefPubMedGoogle Scholar

  • [15]

    Rizvi AM, Irshad M, Hassadi GE, Younis SB. Bioefficacies of Cassia fistula: an Indian labrum. Afr J Pharm Pharmacol. 2009;3:287–92.Google Scholar

  • [16]

    Anonymous. Standardisation of single drugs of unani medicine. Part II & III. New Delhi: Central Council for Research in Unani Medicine, 1997:247–253,151–155.Google Scholar

  • [17]

    Asma K, Sultana A, Rahman K. A single-blind randomized comparative study of Asafoetida vs Mefenamic acid in dysmenorrhoea, associated symptoms and health-related quality of life. J Herbal Med. 2017;9:21–31.CrossrefGoogle Scholar

  • [18]

    Raad J. Rehab measures: short form 12 item (version 2) health survey. Last modified at 8/28/2014 4:33 PM. Available at: http://www.rehabmeasures.org. Accessed: 15 Feb 2015.

  • [19]

    Omidvar S, Esmailzadeh S, Baradaran M, Basirat Z. Effect of fennel on pain intensity in dysmenorrhoea: a placebo-controlled trial. Ayu. 2012;33:311–13.PubMedCrossrefGoogle Scholar

  • [20]

    Direkvand-Moghadam A, Khosravi A. Comparison of verbal multidimensional scoring system (VMS) with visual analogue score (VAS) for evaluating of Shirazi Thymus Vulgaris on menstrual pain. Jpbms. 2012;23:e1–e5.Google Scholar

  • [21]

    Masoumi SZ, Asl HR, Poorolajal J, Panah MH, Oliaei SR. Evaluation of mint efficacy regarding dysmenorrhea in comparison with mefenamic acid: a double blinded randomized crossover study. Iran J Nurs Midwifery Res. 2016;21:363–67.CrossrefPubMedGoogle Scholar

  • [22]

    Kenyon L, King H. Pelvic manipulative benefits women with primary dysmenorrhea. J Am Osteopath Assoc. 2015;115:169–70.CrossrefGoogle Scholar

  • [23]

    Jaiswal P, Kumar P, Singh VK, Singh DK. Biological effects of Myristica fragrans. Annu Rev Biomed Sci. 2009;11:21–29.Google Scholar

  • [24]

    Alia SM, Shamssain M, Shahwan M. Prevalence and impact of dysmenorrhoea on health-related quality of life in the United Arab Emirates. Ejpmr. 2016;3:77–86.Google Scholar

  • [25]

    Onur O, Gumus I, Derbent A, Kaygusuz I, Simavli S, Urun E, et al. Impact of home-based exercise on quality of life of women with primary dysmenorrhoea. SAJOG. 2012;18:1–10 .Google Scholar

  • [26]

    Dhingra D, Sharma A. Antidepressant- like activity of n-hexane extract of nutmeg (Myrstica fragrans) seeds in mice. J Med Food. 2006;9:84–89.PubMedCrossrefGoogle Scholar

  • [27]

    Ziaei S, Zakeri M, Kazemnejad A. A randomised controlled trial of vitamin E in the treatment of primary dysmenorrhoea. Br J Obstet Gynecol. 2005;112:466–69.CrossrefGoogle Scholar

  • [28]

    Heidarifar R, Mehran N, Heidari A, Tehran HA, Koohbor M, Mansourabad MK. Effect of Dill (Anethum graveolens) on the severity of primary dysmenorrhea in compared with mefenamic acid: a randomized, double-blind trial. J Res Med Sci. 2014 Apr;19:326–30.PubMedGoogle Scholar

  • [29]

    Khan A. Haziq, 1st ed. Karachi: Madina Publishing Company, 1983:467–71.Google Scholar

  • [30]

    Asgarpanah J, Kazemivash N. Phytochemistry and pharmacologic properties of Myristica fragrans Houtt.: a review. Afr J Biotech. 2012;11:12787–93.Google Scholar

About the article

Received: 2018-06-26

Accepted: 2018-08-29

Published Online: 2018-10-12

Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: Ministry of AYUSH, India, has funded this trial under unrestricted educational grant for a postgraduate thesis.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report or in the decision to submit the report for publication.

Citation Information: Journal of Complementary and Integrative Medicine, 20180105, ISSN (Online) 1553-3840, DOI: https://doi.org/10.1515/jcim-2018-0105.

Export Citation

© 2018 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in